| Literature DB >> 30987365 |
Haixia Guo1, Huihui Guo2, Li Zhang3, Yijie Fan4, Yupeng Fan5, Zhengmin Tang6, Fanchang Zeng7.
Abstract
The somatic embryogenesis (SE) process of plants, as one of the typical responses to abiotic stresses with hormone, occurs through the dynamic expression of different proteins that constitute a complex regulatory network in biological activities and promotes plant totipotency. Plant SE includes two critical stages: primary embryogenic calli redifferentiation and somatic embryos development initiation, which leads to totipotency. The isobaric labels tandem mass tags (TMT) large-scale and quantitative proteomics technique was used to identify the dynamic protein expression changes in nonembryogenic calli (NEC), primary embryogenic calli (PEC) and globular embryos (GEs) of cotton. A total of 9369 proteins (6730 quantified) were identified; 805, 295 and 1242 differentially accumulated proteins (DAPs) were identified in PEC versus NEC, GEs versus PEC and GEs versus NEC, respectively. Eight hundred and five differentially abundant proteins were identified, 309 of which were upregulated and 496 down regulated in PEC compared with NEC. Of the 295 DAPs identified between GEs and PEC, 174 and 121 proteins were up- and down regulated, respectively. Of 1242 differentially abundant proteins, 584 and 658 proteins were up- and down regulated, respectively, in GEs versus NEC. We have also complemented the authenticity and accuracy of the proteomic analysis. Systematic analysis indicated that peroxidase, photosynthesis, environment stresses response processes, nitrogen metabolism, phytohormone response/signal transduction, transcription/posttranscription and modification were involved in somatic embryogenesis. The results generated in this study demonstrate a proteomic molecular basis and provide a valuable foundation for further investigation of the roles of DAPs in the process of SE transdifferentiation during cotton totipotency.Entities:
Keywords: concerted network; cotton; molecular basis; quantitative proteomics; regulation and metabolism; somatic embryogenesis; transdifferentiation
Mesh:
Substances:
Year: 2019 PMID: 30987365 PMCID: PMC6480670 DOI: 10.3390/ijms20071691
Source DB: PubMed Journal: Int J Mol Sci ISSN: 1422-0067 Impact factor: 5.923
Figure 1Samples used for proteomic assays: (a) Nonembryogenic calli; (b) Primary embryogenic calli; (c) Globular embryos. Bar (a,b) = 2.5 mm; bar (c) = 0.5 mm.
Figure 2Experimental strategy for quantitative proteome analysis and quality control validation of MS data: (a) Mass delta of all identified peptides; (b) Average peptide mass error; (c) Length distribution of all identified peptides. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos. Each staged sample was prepared for three biological replicates.
MS/MS spectrum database search analysis summary.
| Total Spectrum | Matched Spectrum | Peptides | Unique Peptides | Identified Proteins | Quantifiable Proteins |
|---|---|---|---|---|---|
| 360,720 | 74,579 (20.7%) | 45,062 | 27,673 | 9369 | 6730 |
Figure 3Subcellular functional annotation and GO functional classification of identified proteins. (a) Subcellular locations of identified proteins; (b) GO annotation in terms of cellular component; (c) GO annotation in terms of molecular function; (d) GO annotation in terms of biological process. GO: Gene Ontology.
Figure 4Distribution of differentially accumulated proteins (DAPs): (a) Number of up(red)- and down(green)-regulated DAPs in GE vs. NEC, GE vs. PEC and PEC vs. NEC; (b) Venn diagram to show the distribution of DAPs between PEC vs. NEC (blue circle), GE vs. PEC (yellow circle) and GE vs. NEC (green circle). (c) Expression patterns of DAPs. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos.
Figure 5GO functional cluster of differentially accumulated proteins (DAPs) in PEC vs. NEC, GE vs. PEC and GE vs. NEC: (a) GO functional cluster of DAPs in the molecular function; (b) GO cluster of DAPs in the cellular component; (c) GO functional cluster of DAPs in the biological process. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos; GO: Gene Ontology.
Figure 6KEGG cluster and pathway enrichment analysis of DAPs: (a) KEGG clusters in PEC vs. NEC, GE vs. PEC and GE vs. NEC; (b) Pathway enrichment in PEC vs. NEC; (c) Pathway enrichment in GE vs. PEC; (d) Pathway enrichment in GE vs. NEC. The pathway enrichment statistical analysis was performed by Fisher’s exact test. The X-axis is folded enrichment; the y-axis is enrichment pathway. The mapping is the protein number. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos; KEGG: Kyoto encyclopedia of genes and genomes
Figure 7Protein domain enrichment analysis of the differentially accumulated proteins (DAPs) in PEC vs. NEC, GE vs. PEC and GE vs. NEC. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos.
Figure 8GO terms of differentially accumulated proteins (DAPs) in the biological process and the molecular function: (a) The biological process of DAPs in PEC vs. NEC; (b) The biological process and the molecular function of DAPs in GE vs. PEC; (c) The biological process of DAPs in GE vs. NEC. NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos; GO: Gene Ontology.
Significantly representative SE regulatory DAPs in PEC vs. NEC, GE vs. PEC and GE vs. NEC.
| Gene ID | Gene Name | Protein ID | Protein Description | Pathway Annotation | PEC/NEC Ratio | GE/PEC Ratio | GE/NEC Ratio |
|---|---|---|---|---|---|---|---|
| LOC107907377 | PIN2 | A0A120KAE0 | Auxin efflux carrier component | Auxin signal | 2.36 | — | — |
| LOC107909506 | GH3.17 | A0A1U8JQJ4 | Indole-3-acetic acid-amido synthetase GH3.17-like isoform X2 | Auxin signal | 2.14 | — | — |
| LOC107948437 | ETR1 | A0A1U8NHA4 | ethylene receptor-like isoform X1 | Ethylene signal | 2.02 | — | 3.705 |
| LOC107938108 | GASL1 | M1GN42 | GA-stimulated transcript-like protein 1 | GA signal | 0.25 | 0.27 | 0.068 |
| LOC107955576 | GASL4 | M1GMV2 | GA-stimulated transcript-like protein 4 | GA signal | 3.00 | — | |
| LOC107950128 | PYR1 | A0A1U8NR07 | Abscisic acid receptor PYR1-like | ABA signal | — | 2.31 | 2.361 |
| LOC107893363 | At5g01020 | A0A1U8I6G4 | serine/threonine-protein kinase At5g01020-like | Signal transduction | 0.50 | — | 0.482 |
| LOC107897915 | — | A0A1U8IRF6 | A-kinase anchor protein 12-like isoform X2 | Signal transduction | 0.44 | — | 0.459 |
| LOC107909143 | — | A0A1U8JP78 | leucine-rich repeat receptor-like protein kinase PXC2 | Signal transduction | 0.45 | — | 0.36 |
| LOC107945188 | BAM3 | A0A1U8N9I0 | leucine-rich repeat receptor-like Ser/Thr -protein kinase BAM3 | Signal transduction | 2.03 | — | — |
| LOC107935259 | PCKA | A0A1U8M980 | phosphoenolpyruvate carboxykinase [ATP]-like | Signal transduction | 2.08 | 0.38 | — |
| LOC107943515 | At1g56140 | A0A1U8N4H5 | probable LRR receptor-like serine/threonine-protein kinase At1g56140 | Signal transduction | 0.29 | — | 0.215 |
| LOC107931208 | TPK1 | A0A1U8LYM7 | thiamine pyrophosphokinase 1-like isoform X1 | Signal transduction | 0.46 | — | 0.469 |
| LOC107905700 | PFK | A0A1U8JGW8 | ATP-dependent 6-phosphofructokinase | Signal transduction | — | 2.55 | 2.504 |
| LOC107943957 | PV42A | A0A1U8N623 | SNF1-related protein kinase regulatory subunit gamma-like PV42a | Signal transduction | — | 2.83 | 2.757 |
| LOC107937641 | CPK11 | A0A1U8MGW7 | calcium-dependent protein kinase 11-like | Signal transduction | 2.25 | — | 3.84 |
| LOC107930954 | CML27 | A0A1U8LUL1 | probable calcium-binding protein CML27 | Signal transduction | 4.16 | — | 2.88 |
| LOC107916423 | RHN1 | A0A1U8KFK5 | ras-related protein RHN1-like | Signal transduction | — | 0.47 | 0.333 |
| LOC107889787 | — | A0A1U8HV05 | Embryonic protein DC-8-like | Somatic embryogenesis related proteins | — | 3.58 | 4.522 |
| LOC107937048 | Lea2A-A | Q03791 | Embryogenesis abundant protein | Somatic embryogenesis related proteins | — | 4.42 | 4.746 |
| LOC107941722 | WOX9 | A0A1U8MVD7 | WUSCHEL-related homeobox 9-like | Transcription factor | 2.58 | — | — |
| LOC107905698 | NFYB6 | A0A1U8JC47 | Nuclear transcription factor Y subunit B-6 | Transcription factor | 3.22 | 2.07 | 6.661 |
| bHLH4 | W5XUY9 | BHLH4 transcription factor | Transcription factor | 2.16 | — | — | |
| LOC107920272 | NFYB9 | A0A1U8KSD1 | nuclear transcription factor Y subunit B-9-like | Transcription factor | 4.07 | — | 2.509 |
| LOC107931333 | A0A1U8LVZ2 | transcription factor HBP-1b (C38)-like | Transcription factor | 2.40 | — | — | |
| LOC107924015 | PHL1 | A0A1U8L8P3 | Protein PHR1-LIKE 1-like | Transcription factor | 0.15 | — | 0.166 |
| LOC107891610 | At1g07170 | A0A1U8I119 | PHD finger-like domain-containing protein 5B | Zinc finger | 3.49 | — | 4.21 |
| LOC107909066 | NERD | A0A1U8JUI6 | zinc finger CCCH domain-containing protein 19-like isoform X2 | Zinc finger | 2.03 | — | — |
| LOC107927097 | TAF15B | A0A1U8LG36 | transcription TFIID subunit 15b-like | Zinc finger | 0.44 | — | — |
| LOC107962890 | ZHD5 | A0A1U8PUW9 | zinc-finger homeodomain protein 5-like | Zinc finger | — | 2.93 | 5.554 |
| LOC107890886 | AGO1 | A0A1U8HY77 | protein argonaute 1-like isoform X2 | Posttranscriptional regulation | 8.44 | — | 6.734 |
| LOC107906203 | AGO4 | A0A1U8JEA7 | protein argonaute 4-like | Posttranscriptional regulation | 2.38 | — | 2.426 |
| LOC107962954 | HEN1 | A0A1U8PXD5 | small RNA 2’-O-methyltransferase-like isoform X4 | Posttranscriptional regulation | 2.06 | — | — |
| LOC107891032 | IDM1 | A0A1U8HYR9 | increased DNA methylation 1-like isoform X4 | Modification-related protein | 2.62 | 0.49 | — |
| LOC107906306 | MMT1 | A0A1U8JEK1 | Methionine S-methyltransferase | Modification-related protein | 0.46 | — | 0.458 |
| LOC107948568 | SUVH4 | A0A1U8NHS0 | histone-lysine N-methyltransferase, H3 lysine-9 specific SUVH4-like isoform X2 | Modification-related protein | 0.28 | — | 0.196 |
| LOC107943854 | CCOAOMT | A0A1U8N5R4 | caffeoyl-CoA O-methyltransferase -like | Modification-related protein | 0.35 | — | 0.363 |
| LOC107953938 | EMB1691 | A0A1U8P3T9 | methyltransferase-like protein 1 | Modification-related protein | 2.33 | — | 2.774 |
| LOC107916882 | IAMT1 | A0A1U8KGS5 | indole-3-acetate O-methyltransferase 1 | Modification-related protein | 2.32 | — | — |
| LOC107958653 | — | A0A1U8PI31 | chromatin modification-related protein MEAF6-like isoform X3 | Modification-related protein | — | 3.48 | 5.641 |
| LOC107926365 | — | A0A1U8LDK7 | RNA cytidine acetyltransferase | Modification-related protein | 2.17 | — | 2.333 |
| LOC107960303 | — | A0A1U8PLN7 | Acetyltransferase component of pyruvate dehydrogenase complex | Modification-related protein | 0.48 | — | 0.404 |
| LOC107947121 | UBR7 | A0A1U8NDR8 | putative E3 ubiquitin-protein ligase UBR7 | Modification-related protein | 2.90 | — | 2.679 |
| LOC107959749 | RUB2 | A0A1U8PJK7 | ubiquitin-NEDD8-like protein RUB2 | Modification-related protein | 0.26 | — | 0.286 |
| LOC107938100 | — | A0A1U8MII2 | Phosphotransferase | Modification-related protein | 0.42 | — | 0.476 |
| LOC107898863 | CYP86B1 | A0A1U8IP72 | Cytochrome P450 86B1-like | Fatty acid | 4.51 | — | 2.388 |
| LOC107922796 | CYP86A8 | A0A1U8L513 | Cytochrome P450 86A8-like | Fatty acid | 2.02 | — | — |
| LOC107915850 | PIP2-5 | A0A1U8KIL6 | probable aquaporin PIP2-5 | Aquaporins | — | 2.58 | — |
| LOC107898442 | TIP3-2 | A0A1U8IU16 | probable aquaporin TIP3-2 | Aquaporins | — | 2.29 | 9.086 |
| LOC107963873 | GhPIP2;10 | D8FSK4 | Aquaporin PIP210 | Aquaporins | 0.14 | — | 0.102 |
| — | GhTIP1;4 | D8FSK6 | Aquaporin TIP14 | Aquaporins | 0.20 | — | 0.195 |
| LOC107934987 | PIP1;4 | G8XV51 | PIP protein | Aquaporins | 0.22 | — | 0.109 |
DAPs: differentially accumulated proteins; NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos; GO: Gene Ontology.
Figure 9Comparative and complementary proteome of the candidate DAPs in stage of NEC and PEC. Significant differences in expression level were indicated by “*”. DAPs: differentially accumulated proteins; NEC: Nonembryogenic calli; PEC: Primary embryogenic calli; GE: Globular embryos.